Spero Therapeutics Inc. (SPRO) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Spero Therapeutics Inc.

NASDAQ: SPRO · Real-Time Price · USD
2.05
0.02 (0.99%)
At close: Oct 03, 2025, 3:59 PM
2.05
0.00%
After-hours: Oct 03, 2025, 04:10 PM EDT

Spero Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
52.89M 76.33M 109.11M 112.58M
Short-Term Investments
n/a n/a n/a 33.82M
Long-Term Investments
n/a 46.59M n/a n/a
Other Long-Term Assets
153K 435K 10.2M 5.64M
Receivables
52.48M 50.7M 1.08M 2.64M
Inventory
n/a n/a -4.46M n/a
Other Current Assets
1.91M n/a 3.38M n/a
Total Current Assets
107.28M 131.21M 109.11M 157.87M
Property-Plant & Equipment
3.11M 4.16M 5.49M 7.56M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
3.27M 51.18M 15.7M 13.2M
Total Assets
110.54M 182.39M 124.8M 171.07M
Account Payables
7.31M 1.38M 617K 1.1M
Deferred Revenue
22.12M 27.11M 10.37M 1.86M
Short-Term Debt
n/a 1.72M 1.69M 1.36M
Other Current Liabilities
n/a 1.5M -1.24M 7.1M
Total Current Liabilities
49.07M 37.15M 21.65M 18.67M
Long-Term Debt
n/a n/a n/a 48.41M
Other Long-Term Liabilities
576K 23.69M 96K 940K
Total Long-Term Liabilities
15.35M 38.34M 27.22M 64.11M
Total Liabilities
64.42M 75.5M 48.87M 82.78M
Total Debt
4.3M 5.54M 6.65M 55.75M
Book Value
46.12M 106.89M 75.93M 88.29M
Book Value Per Share
0.85 2.03 2.02 2.86
Common Stock
55K 53K 52K 32K
Retained Earnings
-459.64M -391.07M -413.88M -367.46M
Comprehensive Income
n/a n/a n/a -2K
Shareholders Equity
46.12M 106.89M 75.93M 88.29M
Total Investments
n/a 46.59M n/a 33.82M